Food Retail & Distribution

Page 1

Diplomat Pharmacy Inc's Harvoni (ledipasvir/sofosbuvir) approved for the treatment of chronic hepatitis C, genotype 1 infection in adults

Wednesday, 22 Oct 2014 04:53pm EDT

Diplomat Pharmacy Inc:Says U.S. Food and Drug Administration (FDA) announced Oct. 10, that Gilead Sciences Harvoni (ledipasvir/sofosbuvir) product was approved for the treatment of chronic hepatitis C, genotype 1 infection in adults.Harvoni is the first oral combination therapy approved for the treatment of hepatitis C and is also the first treatment regimen that does not require administration with pegylated interferon or ribavirin.

Kesko Oyj to sell store sites; gives guidance for next 12 months

Wednesday, 22 Oct 2014 02:00am EDT

Kesko Oyj:Says is looking into selling some of its store sites to a fund to be set up with Kesko as one of its major investors.Says Kesko's objective is to set up a fund of mainly Kesko-owned store sites and shopping centres in Finland and Sweden with a maximum fair value of about 750 - 950 million euros.Says possible fund is expected to be launched in the course of 2014.Says Kesko Group's net sales and operating profit excluding non-recurring items for the next 12 months are expected to remain at the level of the preceding 12 months.

Cfs Corp, Aeon and WELCIA HOLDINGS announce management integration basic agreement

Wednesday, 22 Oct 2014 02:00am EDT

Cfs Corp:Cfs Corp, Aeon and WELCIA HOLDINGS signed management integration basic agreement on Oct. 22.WELCIA HOLDINGS to acquire Cfs Corp, subsidiary of Aeon through stock swap, with expected effective date on Sep. 1, 2015.

Axfood comments on FY 2014 profit guidance

Wednesday, 22 Oct 2014 01:30am EDT

Axfood AB:Sees profit for FY 2014 to exceed level achieved in FY 2013.

Woolworths Ltd announces no plans to sell BIG W

Tuesday, 21 Oct 2014 10:00pm EDT

Woolworths Ltd:Says that the Australian newspaper reported that Woolworths Limited could be looking at options to sell BIG W.Woolworths says it has no plans to sell BIG W, and notes that this market rumour is incorrect.

Diplomat Pharmacy Inc announces closing of initial public offering and full exercise of over-allotment option by underwriters

Thursday, 16 Oct 2014 02:23pm EDT

Diplomat Pharmacy Inc:Closes its initial public offering of 15,333,333 shares of common stock at an initial public offering price of $13.00 per share, which included 2,000,000 shares sold pursuant to the full exercise of the underwriters' over-allotment option.Diplomat sold 11,000,000 shares of common stock and certain selling shareholders of Diplomat sold 4,333,333 shares of common stock.Company's common stock is listed on the New York Stock Exchange under the symbol DPLO.Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC acted as lead book-running managers.Additional book-running managers were J.P. Morgan Securities LLC and Wells Fargo Securities, LLC. William Blair & Company, L.L.C. and Leerink Partners LLC acted as co-managers.

A. C. Simmonds and Sons acquires 100 pct of BioSec Enviro

Thursday, 16 Oct 2014 11:13am EDT

A. C. Simmonds and Sons:Closes the acquisition of 100 pct of the shares of BioSec Enviro Inc.

SUPERVALU Inc reaffirms FY 2015 EBITDA guidance - Conference Call

Thursday, 16 Oct 2014 10:00am EDT

SUPERVALU Inc:Continues to believe FY 2015 adjusted EBITDA will be lower than FY 2014 pro forma adjusted EBITDA of $783 million.FY 2015 EBITDA of $769 million - Thomson Reuters I/B/E/S.

Booker Group Plc declares interim dividend

Thursday, 16 Oct 2014 02:00am EDT

Booker Group Plc:Declares an interim dividend of 0.0052 pounds per share.Payable on Nov. 28 to shareholders on the register at the close of business on Oct. 31.

Lenta Ltd reaffirms FY 2014 sale guidance

Thursday, 16 Oct 2014 02:00am EDT

Lenta Ltd:Says sales growth guidance for FY 2014 remains unchanged at 34-38 pct.FY 2014 revenue of 200.074 mln Roubles - Thomson Reuters I/B/E/S.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Bohai Securities Co.,Ltd.
$92.00
Provider: Wright Reports
$75.00
Provider: Wright Reports
$35.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.